Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beneficient (BENF) EBT (2021 - 2025)

Beneficient (BENF) has disclosed EBT for 5 consecutive years, with $5.9 million as the latest value for Q4 2025.

  • Quarterly EBT rose 162.44% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$149.9 million through Dec 2025, changed 0.28% year-over-year, with the annual reading at -$723000.0 for FY2025, 99.97% up from the prior year.
  • EBT hit $5.9 million in Q4 2025 for Beneficient, up from -$17.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $44.3 million in Q2 2024 to a low of -$1.2 billion in Q2 2023.
  • Historically, EBT has averaged -$185.6 million across 5 years, with a median of -$49.0 million in 2023.
  • Biggest five-year swings in EBT: crashed 1945.74% in 2023 and later surged 162.44% in 2025.
  • Year by year, EBT stood at -$29.9 million in 2021, then tumbled by 51.25% to -$45.2 million in 2022, then plummeted by 1945.74% to -$924.8 million in 2023, then soared by 98.97% to -$9.5 million in 2024, then soared by 162.44% to $5.9 million in 2025.
  • Business Quant data shows EBT for BENF at $5.9 million in Q4 2025, -$17.9 million in Q3 2025, and -$92.6 million in Q2 2025.